Scientists have long figured it would be possible to induce the immune system to attack tumors and fight diseases, but decades of work haven't yielded much--until now. FierceVaccines spotlights some vaccines currently being tested in humans and generating buzz. Report
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments